{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:43:11Z","timestamp":1793662991874,"version":"4.5.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.aohep.2026.102192","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:29:27Z","timestamp":1769790567000},"page":"102192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["ALEH position statement on the management of hepatitis B virus infection 2025"],"prefix":"10.1016","volume":"31","author":[{"given":"Mario Guimar\u00e3es","family":"Pessoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelia","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela Castro","family":"Narro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo A.","family":"Mattos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1136-9554","authenticated-orcid":false,"given":"Alejandro","family":"Soza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Dagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3585-3666","authenticated-orcid":false,"given":"Martin","family":"Padilla-Machaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Garavito-Renter\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier Hern\u00e1ndez","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Cheinquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Gadano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3321-0683","authenticated-orcid":false,"given":"Ezequiel","family":"Ridruejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2026.102192_bib0001","unstructured":"World Health Organization. Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022\u20132030: Report on progress and gaps 2024, second edition. https:\/\/iris.who.int\/bitstream\/handle\/10665\/378246\/9789240097872-eng.pdf?sequence=1. Geneva: WHO; 2024. (accessed March 21, 2025)."},{"key":"10.1016\/j.aohep.2026.102192_bib0002","series-title":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection, 2024","year":"2024"},{"key":"10.1016\/j.aohep.2026.102192_bib0003","series-title":"PAHO disease elimination initiative. a policy for an integrated sustainable approach to communicable diseases in the Americas","first-page":"2023","year":"2019"},{"key":"10.1016\/j.aohep.2026.102192_bib0004","article-title":"European Association for the study of the liver. EASL clinical practice guidelines on the management of hepatitis B virus infection","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102192_bib0005","unstructured":"\u201cHepatitis B en ind\u00edgenas de Am\u00e9rica Latina: una revisi\u00f3n de la literatura.\u201d Accessed: Jan. 19, 2025. [Online]. Available: https:\/\/iris.paho.org\/handle\/10665.2\/55837"},{"key":"10.1016\/j.aohep.2026.102192_bib0006","article-title":"AASLD\/IDSA practice guideline on treatment of chronic hepatitis B","author":"Ghany","year":"2025","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.aohep.2026.102192_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159509","article-title":"Analysis of the molecular evolution of Hepatitis B virus genotypes in symptomatic acute infections in Argentina","volume":"11","author":"Rodrigo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2026.102192_bib0008","doi-asserted-by":"crossref","unstructured":"Panduro A, Roman S, Laguna-Meraz S, Jose-Abrego A. Hepatitis B virus genotype H: epidemiological, molecular, and clinical characteristics in Mexico. Viruses. 2023 Oct 30;15(11):2186. doi: 10.3390\/v15112186.","DOI":"10.3390\/v15112186"},{"issue":"3","key":"10.1016\/j.aohep.2026.102192_bib0009","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bpg.2017.04.010","article-title":"Natural history of acute and chronic hepatitis B: the role of HBV genotypes and mutants","volume":"31","author":"Lin","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.aohep.2026.102192_bib0010","series-title":"WHO guidelines on hepatitis B and C testing","year":"2017"},{"issue":"7","key":"10.1016\/j.aohep.2026.102192_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235036","article-title":"Sensitivity and specificity of commercially available rapid diagnostic tests for viral hepatitis B and C screening in serum samples","volume":"15","author":"Jargalsaikhan","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.aohep.2026.102192_bib0012","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1038\/s41598-023-33925-2","article-title":"HIV AND HBV rapid test diagnosis in non-clinical outreach settings can be as accurate as conventional laboratory tests","volume":"13","author":"Mu\u00f1oz-Chimeno","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.aohep.2026.102192_bib0013","doi-asserted-by":"crossref","first-page":"354","DOI":"10.47892\/rgp.2024.444.1806","article-title":"Acceptability and screening outcomes for hepatitis B, C and human inmunodeficiency virus using rapid diagnostic tests in patients undergoing outpatient endoscopy","volume":"44","author":"Mu\u00f1oz","year":"2024","journal-title":"Rev Gastroenterol Peru"},{"issue":"1","key":"10.1016\/j.aohep.2026.102192_bib0014","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"REVEAL-HBV Study group. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.aohep.2026.102192_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218369","article-title":"Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care","volume":"14","author":"Agutu","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.aohep.2026.102192_bib0016","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41591-023-02247-1","article-title":"Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial","volume":"29","author":"Esmail","year":"2023","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.aohep.2026.102192_bib0018","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2016.08.009","article-title":"The role of quantitative hepatitis B surface antigen revisited","volume":"66","author":"Cornberg","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2026.102192_bib0019","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jhep.2022.12.017","article-title":"A critique and systematic review of the clinical utility of hepatitis B core-related antigen","volume":"78","author":"Adraneda","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2026.102192_bib0020","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/hep.30325","article-title":"Serum Hepatitis B Virus RNA: A new potential biomarker for chronic Hepatitis B virus infection","volume":"69","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2026.102192_bib0021","doi-asserted-by":"crossref","unstructured":"Fuster F, Peirano F, Vargas JI, Zamora FX, L\u00f3pez-Lastra M, N\u00fa\u00f1ez R, Soza J, Gonz\u00e1lez K, Estay D, Barchiesi B, Fuster A, L\u00f3pez I, Utrera N, Landeros J, Chand\u00eda J, Paredes A, Reyes D, Arias R, Padilla L, Su\u00e1rez H, Farcas K, Cannistra M, Mu\u00f1oz G, Rodr\u00edguez I, Ormaz\u00e1bal I, Cort\u00e9s J, Cornejo B, Manzur F, Reyes A, Leiva V, Raimann MV, Arrau C, Cox V, Soza A. Infectious and non-infectious diseases burden among Haitian immigrants in Chile: a cross-sectional study. Sci Rep. 2020 Dec 17;10(1):22275. doi: 10.1038\/s41598-020-78970-3.","DOI":"10.1038\/s41598-020-78970-3"},{"key":"10.1016\/j.aohep.2026.102192_bib0022","author":"Organization","year":"2020","journal-title":"World Health Org"},{"key":"10.1016\/j.aohep.2026.102192_bib0023","doi-asserted-by":"crossref","first-page":"21","DOI":"10.11604\/pamj.2022.43.21.36041","article-title":"Diagnostic performances of Exacto\u00ae Triplex rapid test for diagnosis of HIV\/HCV\/HBsAg: a multicenter, cross-sectional, field study in the Central African Republic","volume":"43","author":"Mossoro-Kpinde","year":"2022","journal-title":"Pan Afr Med J"},{"issue":"4","key":"10.1016\/j.aohep.2026.102192_bib0024","first-page":"403","article-title":"Asociaci\u00f3n Mexicana de hepatolog\u00eda A.C. Clinical guideline on hepatitis B","volume":"86","author":"Higuera-de-la-Tijera","year":"2021","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"key":"10.1016\/j.aohep.2026.102192_bib0025","unstructured":"https:\/\/www.hepatitisc.uw.edu\/page\/clinical-calculators\/apri"},{"issue":"3","key":"10.1016\/j.aohep.2026.102192_bib0026","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.aohep.2026.102192_bib0027","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-158-11-201306040-00005","article-title":"Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review","volume":"158","author":"Chou","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aohep.2026.102192_bib0028","unstructured":"https:\/\/www.hepatitisc.uw.edu\/page\/clinical-calculators\/fib-4"},{"issue":"6","key":"10.1016\/j.aohep.2026.102192_bib0029","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"APRICOT Clinical Investigators. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2026.102192_bib0030","unstructured":"https:\/\/www.mskcc.org\/es\/cancer-care\/patient-education\/understanding-your-fibroscan-results"},{"issue":"12","key":"10.1016\/j.aohep.2026.102192_bib0031","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"issue":"Suppl 1","key":"10.1016\/j.aohep.2026.102192_bib0032","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/jpids\/piu064","article-title":"Prevention of perinatal Hepatitis B virus transmission","volume":"3","author":"Nelson","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.aohep.2026.102192_bib0033","doi-asserted-by":"crossref","unstructured":"Mironova M, Ghany MG. Hepatitis B vaccine: four decades on. Vaccines (Basel). 2024 Apr 18;12(4):439. doi: 10.3390\/vaccines12040439.","DOI":"10.3390\/vaccines12040439"},{"key":"10.1016\/j.aohep.2026.102192_bib0034","series-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016\u20132021: actions for impact","year":"2021"},{"issue":"4","key":"10.1016\/j.aohep.2026.102192_bib0035","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jhep.2012.05.021","article-title":"Minimization of hepatitis B infection by a 25-year universal vaccination program","volume":"57","author":"Ni","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102192_bib0036","doi-asserted-by":"crossref","unstructured":"Cui F, Shen L, Li L, Wang H, Wang F, Bi S, Liu J, Zhang G, Wang F, Zheng H, Sun X, Miao N, Yin Z, Feng Z, Liang X, Wang Y. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017 May;23(5):765-772. doi: 10.3201\/eid2305.161477.","DOI":"10.3201\/eid2305.161477"},{"key":"10.1016\/j.aohep.2026.102192_bib0037","series-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","year":"2024"},{"issue":"43","key":"10.1016\/j.aohep.2026.102192_bib0038","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.15585\/mmwr.mm7043a1","article-title":"Routine vaccination coverage - worldwide, 2020","volume":"70","author":"Muhoza","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.aohep.2026.102192_bib0039","doi-asserted-by":"crossref","unstructured":"Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of Hepatitis B Virus infection and impact of vaccination on disease. Clin Liver Dis. 2016 Nov;20(4):607-628. doi: 10.1016\/j.cld.2016.06.006. Erratum in: Clin Liver Dis. 2017 May;21(2):xiii. d o i: 10.1016\/j.cld.2017.02.002.","DOI":"10.1016\/j.cld.2016.06.006"},{"key":"10.1016\/j.aohep.2026.102192_bib0040","doi-asserted-by":"crossref","unstructured":"Jeng WJ, Papatheodoridis GV, Lok ASF. Hepatitis B. Lancet. 2023 Mar 25;401(10381):1039-1052. doi: 10.1016\/S0140-6736(22)01468-4.","DOI":"10.1016\/S0140-6736(22)01468-4"},{"issue":"1","key":"10.1016\/j.aohep.2026.102192_bib0041","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1473-3099(20)30586-7","article-title":"Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis","volume":"21","author":"Funk","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.aohep.2026.102192_bib0042","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(20)30593-4","article-title":"Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis","volume":"21","author":"Boucheron","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.aohep.2026.102192_bib0043","doi-asserted-by":"crossref","unstructured":"Delamare H, Ishii-Rousseau JE, Rao A, Cresta M, Vincent JP, S\u00e9g\u00e9ral O, Nayagam S, Shimakawa Y. Proportion of pregnant women with HBV infection eligible for antiviral prophylaxis to prevent vertical transmission: A systematic review and meta-analysis. JHEP Rep. 2024 Mar 26;6(8):101064. doi: 10.1016\/j.jhepr.2024.101064.","DOI":"10.1016\/j.jhepr.2024.101064"},{"issue":"7","key":"10.1016\/j.aohep.2026.102192_bib0044","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S2468-1253(23)00074-2","article-title":"Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study","volume":"8","author":"Nayagam","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102192_bib0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12072-020-10026-0","article-title":"Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis","volume":"14","author":"Wu","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2026.102192_bib0046","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2147\/IJGM.S289804","article-title":"Breast-feeding is not a risk factor of mother-to-child transmission of Hepatitis B virus","volume":"14","author":"Zhou","year":"2021","journal-title":"Int J Gen Med"},{"issue":"5","key":"10.1016\/j.aohep.2026.102192_bib0047","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1053\/j.gastro.2024.06.014","article-title":"AGA clinical practice update on pregnancy-related gastrointestinal and liver disease: expert review","volume":"167","author":"Kothari","year":"2024","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.aohep.2026.102192_bib0048","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1473-3099(22)00206-7","article-title":"Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial","volume":"22","author":"Segeral","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.aohep.2026.102192_bib0049","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/aogs.14448","article-title":"Incidence of mother-to-child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta-analysis","volume":"101","author":"Yao","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.aohep.2026.102192_bib0050","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jhep.2023.03.006","article-title":"European Association for the study of the liver. EASL clinical practice guidelines on the management of liver diseases in pregnancy","volume":"79","year":"2023","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2026.102192_bib0051","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","volume":"8","author":"Collaborators","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102192_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"issue":"12","key":"10.1016\/j.aohep.2026.102192_bib0053","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/jvh.13185","article-title":"The risk of hepatocellular carcinoma among chronic hepatitis B virus-infected patients outside current treatment criteria","volume":"26","author":"Sinn","year":"2019","journal-title":"J Viral Hepat"},{"issue":"4","key":"10.1016\/j.aohep.2026.102192_bib0054","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jvh.12643","article-title":"Determination of hepatitis B phenotype using biochemical and serological markers","volume":"24","author":"Di Bisceglie","year":"2017","journal-title":"J Viral Hepat"},{"issue":"8","key":"10.1016\/j.aohep.2026.102192_bib0055","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.cgh.2021.01.019","article-title":"Natural history and hepatocellular carcinoma risk in untreated chronic Hepatitis B patients with indeterminate phase","volume":"20","author":"Huang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102192_bib0056","first-page":"e0226","article-title":"HBV elimination in Central & South America- current status and challenges","volume":"23","author":"Haddad","year":"2024","journal-title":"Clin Liv Dis"},{"issue":"6","key":"10.1016\/j.aohep.2026.102192_bib0057","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2012.01.044","article-title":"Effectiveness of hepatitis B treatment in clinical practice","volume":"142","author":"Scaglione","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2026.102192_bib0058","doi-asserted-by":"crossref","unstructured":"Lee SK, Kwon JH, Lee SW, Jang JW, Nam H, Baik KW, Yoo SH, Nam SW, Sung PS, Bae SH, Choi JY, Yoon SK. Sustained off therapy response after peglyated interferon favours functional cure and no disease progression in chronic hepatitis B. Liver Int. 2021 Feb;41(2):288-294. doi: 10.1111\/liv.14701.","DOI":"10.1111\/liv.14701"},{"key":"10.1016\/j.aohep.2026.102192_bib0059","doi-asserted-by":"crossref","unstructured":"Dandri M, Petersen J. cccDNA maintenance in chronic Hepatitis B - targeting the matrix of viral replication. Infect Drug Resist. 2020 Oct 29;13:3873-3886. doi: 10.2147\/IDR.S240472.","DOI":"10.2147\/IDR.S240472"},{"issue":"5","key":"10.1016\/j.aohep.2026.102192_bib0060","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jhep.2023.06.002","article-title":"2022 AASLD-EASL HBV-HDV treatment endpoints conference faculty. Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV treatment endpoints conference","volume":"79","author":"Ghany","year":"2023","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2026.102192_bib0061","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s12072-022-10411-x","article-title":"Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort","volume":"16","author":"Hsu","year":"2022","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.aohep.2026.102192_bib0062","doi-asserted-by":"crossref","first-page":"271","DOI":"10.14309\/ajg.0000000000000428","article-title":"Tenofovir versus Entecavir for hepatocellular carcinoma prevention in an International Consortium of Chronic Hepatitis B","volume":"115","author":"Hsu","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.aohep.2026.102192_bib0063","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S2468-1253(20)30249-1","article-title":"Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis","volume":"5","author":"Tseng","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102192_bib0064","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhep.2022.12.007","article-title":"Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: individual patient data meta-analysis","volume":"78","author":"Choi","year":"2023","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2026.102192_bib0065","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/jgh.16537","article-title":"Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study","volume":"39","author":"Jang","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2026.102192_bib0066","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/liv.14155","article-title":"Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection","volume":"39","author":"Marcellin","year":"2019","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.aohep.2026.102192_bib0067","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra2211764","article-title":"New approaches to chronic Hepatitis B","volume":"388","author":"Dusheiko","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.aohep.2026.102192_bib0068","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jhep.2017.11.039","article-title":"GS-US-320-0110; GS-US-320-0108 investigators. 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection","volume":"68","author":"Agarwal","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2026.102192_bib0069","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jhep.2022.01.007","article-title":"Maasoumy B; CREATE study group. Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels","volume":"76","author":"Sonneveld","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102192_bib0070","doi-asserted-by":"crossref","unstructured":"Lok ASF. Toward a functional cure for Hepatitis B. Gut liver. 2024 Jul 15;18(4):593-601. doi: 10.5009\/gnl240023.","DOI":"10.5009\/gnl240023"},{"issue":"3","key":"10.1016\/j.aohep.2026.102192_bib0071","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1053\/j.gastro.2021.11.002","article-title":"RETRACT-B Study group. Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic Hepatitis B: an international, multicenter, multiethnic cohort (RETRACT-B Study)","volume":"162","author":"Hirode","year":"2022","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.aohep.2026.102192_bib0072","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/liv.14357","article-title":"New epidemiology of hepatitis delta","volume":"40","author":"Vlachogiannakos","year":"2020","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.aohep.2026.102192_bib0073","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/liv.13604","article-title":"Hepatitis Delta International Network. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: the Hepatitis Delta International Network (HDIN)","volume":"38","author":"Wranke","year":"2018","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.aohep.2026.102192_bib0074","first-page":"647","article-title":"Hepatitis D Virus: a call to screening","volume":"10","author":"Ahn","year":"2014","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"8","key":"10.1016\/j.aohep.2026.102192_bib0075","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/jmv.25196","article-title":"Hepatitis D infection in Brazil: prevalence and geographical distribution of anti-delta antibody","volume":"90","author":"Lago","year":"2018","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102192_bib0076","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jhep.2023.10.043","article-title":"Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories","volume":"80","year":"2024","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2026.102192_bib0077","first-page":"378","article-title":"Viral hepatitis B and Delta in Peru: epidemiology and basis for control","volume":"24","author":"Cabezas","year":"2007","journal-title":"Rev Peru Med Exp Salud Publica"},{"issue":"6","key":"10.1016\/j.aohep.2026.102192_bib0078","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234273","article-title":"Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: a cross-sectional study","volume":"15","author":"Cabezas","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.aohep.2026.102192_bib0079","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"EASL clinical practice guidelines on hepatitis delta virus","volume":"79","year":"2023","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102192_bib0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jvh.13779","article-title":"The delta delta: gaps in screening and patient assessment for hepatitis D virus infection","volume":"30","author":"Nathani","year":"2023","journal-title":"J Viral Hepat"},{"issue":"4","key":"10.1016\/j.aohep.2026.102192_bib0081","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cld.2023.05.012","article-title":"What is the path forward to treat Hepatitis Delta virus?: old treatments and new options","volume":"27","author":"Asselah","year":"2023","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.aohep.2026.102192_bib0082","article-title":"Alignment of countries in the Americas with the latest WHO guidelines for hepatitis B virus (HBV) infection: a review","volume":"39","author":"Perazzo","year":"2024","journal-title":"Lancet Reg Health Am"},{"issue":"12","key":"10.1016\/j.aohep.2026.102192_bib0083","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.3390\/v13122371","article-title":"A rapid point-of-care test for the serodiagnosis of Hepatitis Delta virus infection","volume":"13","author":"Lempp","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.aohep.2026.102192_bib0084","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of Hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.aohep.2026.102192_bib0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.15585\/mmwr.mm7113a1","article-title":"Universal Hepatitis B vaccination in adults aged 19\u201359 years: updated recommendations of the advisory committee on immunization practices \u2014 United States, 2022","volume":"71","author":"Weng","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812600013X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812600013X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:14:59Z","timestamp":1776788099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S166526812600013X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S166526812600013X"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102192","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALEH position statement on the management of hepatitis B virus infection 2025","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102192"}}